Unfortunately, a critical limiting problem is that these antigens (CD44, EGFR, and TFRC) are also expressed on normal brain tissue at high levels37–39, and consequently are non-specific and cannot differentiate between GBM and normal brain cells. This evidence concerns the gene TFRC and glioblastoma.